Biocon Q3 results: Company posts net profit at Rs 660 crore

"A key milestone this quarter was the successful conclusion of the transition of the acquired business by Biocon Biologics and a pre-payment of USD 200 million towards the acquisition-related debt reduction," Biocon Executive Chairperson Kiran Mazumdar Shaw said.

Biocon Q3 results: Company posts net profit at Rs 660 crore
Total revenue rose to Rs 4,519 crore in the third quarter as against Rs 3,020 crore in the year-ago period, Biocon Ltd said in a statement. Image Courtesy: bioconacademy.com

Biotech firm Biocon on Thursday reported a consolidated net profit of Rs 660 crore for the third quarter ended December 31, 2023, on the back of robust sales. The company had reported a net loss of Rs 42 crore in the October-December period of last fiscal.

Total revenue rose to Rs 4,519 crore in the third quarter as against Rs 3,020 crore in the year-ago period, Biocon Ltd said in a statement.

"A key milestone this quarter was the successful conclusion of the transition of the acquired business by Biocon Biologics and a pre-payment of USD 200 million towards the acquisition-related debt reduction," Biocon Executive Chairperson Kiran Mazumdar Shaw said.

Steady market shares for key biosimilars in the US and EU were complemented by the emerging markets performance which saw a number of new product launches and tender wins, she added.

Catch the latest stock market updates here. For all other news related to business, politics, tech, sports, and auto, visit Zeebiz.com.

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

RECOMMENDED STORIES

https://www.zeebiz.com/personal-finance/photo-gallery-latest-fd-interest-rates-for-senior-citizens-know-what-major-banks-like-icici-bank-hdfc-bank-of-baroda-sbi-canara-bank-axis-bank-providing-currently-on-fixed-deposits-calculator-327278

Senior Citizen Latest FD Rates: Know what major banks like SBI, PNB, Canara Bank, HDFC Bank, ICICI Bank are providing on fixed deposits

https://www.zeebiz.com/personal-finance/photo-gallery-gratuity-calculator-inr-rs-38000-as-last-drawn-basic-salary-pay-and-5-years-5-months-of-service-know-gratuity-amount-payment-act-1972-eligibility-criteria-conditions-employer-employees-wage-327018

Gratuity Calculator: Rs 38,000 as last-drawn basic salary, 5 years and 5 months of service; what will be gratuity amount?

https://www.zeebiz.com/personal-finance/photo-gallery-epfo-retirement-pension-scheme-early-pension-superannuation-disablement-widow-child-orphan-pension-online-login-passbook-employee-provident-fund-327598

EPFO Pension Schemes: Early pension, retirement pension, nominee pension and 4 other pension schemes that every private sector employee should know

https://www.zeebiz.com/trending/photo-gallery-delhi-aqi-today-air-pollution-level-falls-to-very-poor-quality-schools-closed-work-from-home-started-in-office-government-bans-firecrackers-sale-on-ecommerce-sites-city-records-lowest-temperature-327481

Delhi AQI Today: Air quality index level drops; city records season's lowest temperature

https://www.zeebiz.com/personal-finance/photo-gallery-top-5-small-cap-mutual-funds-with-best-sip-xirr-returns-in-1-year-calculator-inr-rs-25000-monthly-investment-has-grown-to-355000-nifty-150-tri-bse-invesco-edelweiss-hsbc-franklin-nav-aum-327419

Top 5 Small Cap Mutual Funds with best SIP returns in 1 year: See how Rs 25,000 monthly investment has grown in each scheme

https://www.zeebiz.com/personal-finance/photo-gallery-top-7-sbi-sip-mutual-funds-with-highest-sip-return-xirr-in-1-year-capital-gains-calculator-how-inr-rs-25000-monthly-investment-has-grown-to-bse-sp-nifty-multi-large-health-tech-banking-326674

Top 7 SBI Mutual Funds With Best SIP Returns in 1 Year: Rs 25,000 monthly SIP investment in No.1 fund has jumped to Rs 3,58,404

https://www.zeebiz.com/markets/stocks/photo-gallery-adani-group-stocks-nosedive-heres-what-anil-singhvi-suggests-327508

Adani group stocks nosedive: Buy or Sell? Here's what Anil Singhvi says

https://www.zeebiz.com/personal-finance/photo-gallery-sbi-state-bank-of-india-5-years-fixed-deposit-fd-vs-post-office-monthly-income-scheme-mis-where-can-you-get-more-income-in-5-years-on-investment-of-rs-200000-see-calculations-327293

SBI 5-Year FD vs MIS: Which can offer higher returns on a Rs 2,00,000 investment over 5 years? See calculations

https://www.zeebiz.com/trending/news-rains-in-tamil-nadu-orange-alert-issues-for-november-26-regional-meteorological-centre-cyclone-south-andaman-sea-puducherry-karaikkal-327505

Tamil Nadu Weather News: Heavy rain likely in TN, orange alert issued for Nov 26

https://www.zeebiz.com/markets/stocks/photo-gallery-psu-and-largecap-shares-to-buy-short-term-bse-sensex-nse-nifty-pick-of-the-day-327460

Stocks to buy: Hindustan Aeronautics, Zomato, Tata Tech, GMR Airports among analysts' top picks

Written By: PTI
Updated: Thu, Feb 08, 2024
10:33 PM IST
PTI
RELATED NEWS
Should you buy, sell or hold L&T, Tata Power, Biocon, other stocks now? Should you buy, sell or hold L&T, Tata Power, Biocon, other stocks now?
Biocon gets 4 observations from USFDA for Bengaluru API facility Biocon gets 4 observations from USFDA for Bengaluru API facility
LIC raises stake in Biocon to 5.02% LIC raises stake in Biocon to 5.02%
Biocon Biologics got approval from the European Medicines Agency to manufacture biosimilar Bevacizumab in India Biocon Biologics got approval from the European Medicines Agency to manufacture biosimilar Bevacizumab in India

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x